Research Article
Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer
Figure 5
Effects of combination of bezafibrate and GSK126 on CDX tumor volumes. (a) Representative image of bearing tumors of PANC-1 in each experimental group. (b) Representative image of bearing tumors of AsPC-1 in each experimental group. (c) Growth curves of bearing tumors of PANC-1 in each experimental group. (d) Growth curves of bearing tumors of AsPC-1 in each experimental group. The values were expressed as the ( for each group). vs. control; # vs. the GSK126 group.
(a) |
(b) |
(c) |
(d) |